US restricts use of Johnson & Johnson Covid vaccine over rare blood clot risk

JUST IN – US regulators strictly limit who can receive Johnson & Johnson’s COVID vaccine over “rare but serious” blood clots risk.

US regulators on Thursday strictly limited who can receive Johnson & Johnson’s Covid-19 vaccine due to a rare but serious risk of blood clots.

Three men stand behind a makeshift jail grate. The two on either end are holding enlarged needles with the word 'vaccine' on them. A sign in front of them says 'Unlock vaccines. End big pharma monopolies.'

The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request Johnson & Johnson’s vaccine. US authorities for months have recommended that Americans starting their Covid-19 vaccinations use the Pfizer or Moderna shots instead.